Matthew B. Soellner

University of Michigan–Ann Arbor — United States

Computer Science · Physical Sciences

24h-index2.6kcitations157works7.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Computational Drug Discovery Methods(42), Brain Metastases and Treatment(36), Click Chemistry and Applications(31), Radiopharmaceutical Chemistry and Applications(26), Lung Cancer Treatments and Mutations(21)

Publications155 total

PT1.03.01 Precision Medicine Platform to Guide the Treatment of NSCLC
Journal of Thoracic Oncology·2025
EP.02.07 Enhancing Alectinib Efficacy in ALKPositive Non-Small Cell Lung Cancer by Targeting Mtor
Journal of Thoracic Oncology·2025
TRLS-04 ENHANCING PRECISION MEDICINE THROUGH FUNCTIONAL DRUG TESTING FOR PATIENTS WITH BREAST CANCER BRAIN METASTASES.
Neuro-Oncology Advances·2025Open Access
Abstract 491: Molecular correlates of drug response to identify novel therapeutic combinations in triple-negative breast cancer
Cancer Research·2025
PCO25-212: Examining Molecular Features of Rare Brain Metastases Patient-Derived Xenograft Models
Journal of the National Comprehensive Cancer Network·2025
Abstract B013: Precision medicine platform to guide the treatment of NSCLC
Cancer Research·2025· 1 cited
8P Precision medicine drug testing platform to guide the treatment of EML4-ALK fusion lung cancers
ESMO Open·2024Open Access
Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine Response
European Urology·2024· 18 cited
Examining molecular landscape and drug sensitivity profiles of patient-derived xenografts from resected brain metastases.
Journal of Clinical Oncology·2024
Precision medicine-based platform to guide the treatment of EML4-ALK driven lung cancers and other NSCLC in real time.
Journal of Clinical Oncology·2024
Targeting fatty acid synthase in preclinical models of TNBC brain metastases synergizes with SN-38 and impairs invasion
npj Breast Cancer·2024· 24 citedOpen Access
A selective, turn-on fluorescent probe for live-cell super-resolution imaging of c-Src kinase
2024· 1 citedOpen Access
Abstract B020: Development of novel Src-targeting strategies to block bladder cancer invasive progression
Clinical Cancer Research·2024
Abstract A009: Integrative drug screening and multi-omic characterization of patient-derived bladder cancer organoids reveals novel molecular correlates of chemotherapy response
Clinical Cancer Research·2024
Abstract PO3-06-12: Targeting Fatty Acid Synthase in Brain Metastatic Triple-negative Breast Cancer
Cancer Research·2024
Abstract PO2-16-01: Molecular correlates of drug response to guide therapy in triple-negative breast cancer
Cancer Research·2024
Abstract 4548: Discovering novel ALK-lung carcinoma therapeutic strategies by identifying combinations with Alectinib from ALK-positive lung carcinoma cell lines
Cancer Research·2024
Abstract 351: Quaratusugene ozeplasmid mediated TUSC2 upregulation in EML4-ALK bearing non-small cell lung carcinoma can induce cellular apoptosis
Cancer Research·2024
Abstract 223: Precision medicine-based platform to guide the treatment of EML4-ALK fusion lung cancers and other NSCLC
Cancer Research·2024
Selective and Potent PROTAC Degraders of c-Src Kinase
ACS Chemical Biology·2023· 12 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Ronald T. Raines(12), Sofía D. Merajver(11), Sameer Phadke(10), Eric J. Lachacz(10), Michael E. Steffey(9), Taylor K. Johnson(9), Frank E. Kwarcinski(8), Nathalie M. Vandecan(8), Bradley L. Nilsson(6), Kristoffer Brandvold(6), Christel C. Fox(6), Michael P. Agius(6), Nathan Merrill(6), Liwei Bao(5), Daniel A. Bochar(5), Annie Tam(4), Kristin S. Ko(4), Meghan E. Breen(4), Aki Morikawa(4), Peter Ulintz(4)